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Abstract
Objective—Longitudinal studies have shown an increase in cognitive decline many years prior to 
clinical diagnosis of dementia. We sought to estimate changes, relative to “normal” aging, in the 
trajectory of a global cognitive function test - the Cognitive Abilities Screening Instrument 
(CASI).
Design—A cohort of cognitively intact elderly participants, assessed biennially for dementia for 
up to 20 years.
Setting—Community dwelling elderly enrolled in a health maintenance organization.
Participants—Four thousand three hundred fifteen participants aged 65 and older who had no 
dementia diagnosis at baseline and had at least 2 visits with valid CASI test score.
Measurements—Average longitudinal trajectories, including changes in trajectory prior to 
clinical diagnosis in those who would be diagnosed with dementia, were estimated for CASI item 
response theory (IRT) scores. The impact of sex, education level, and APOE genotype on 
cognitive trajectories was assessed.
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Results—Increased cognitive decline relative to “normal” aging was evident in CASI IRT at least 
10 years prior to clinical diagnosis. Male gender, lower education, and presence of ≥1 APOE ε4 
alleles were associated with lower average IRT scores. In those who would be diagnosed with 
dementia, a trajectory change-point was estimated at an average of 3.1 years (95% confidence 
interval 3.0, 3.2) prior to clinical diagnosis, after which cognitive decline appeared to accelerate. 
The change-point did not differ by sex, education level, or APOE ε4 genotype. There were subtle 
differences in trajectory slopes by sex and APOE ε4 genotype, but not by education.
Conclusion—Decline in average global cognitive function was evident at least 10 years prior to 
clinical diagnosis of dementia. The decline accelerated about 3 years prior to clinical diagnosis.
Keywords
dementia; cognitive function; trajectory changes; change-point
Introduction
Neurodegenerative changes begin years before the clinical diagnosis of Alzheimer's disease 
(AD)1-3 and there is great interest in identifying early clinical manifestations of underlying 
brain changes for early intervention. Several large community-based studies4-7 reported 
cognitive decline starting as early as 15-16 years prior to dementia diagnosis, followed by 
acceleration of decline closer to diagnosis.4-6 We will refer to the initiation of accelerated 
decline as a trajectory “change-point”. Estimates of timing of the change-point vary widely 
in different populations and with different measures of cognition, with studies indicating an 
accelerated decline in cognitive trajectory commencing at 1 to 17 years prior to AD or 
dementia diagnosis.3, 8-16
Estimates of the effect of education and presence of APOE ε4 alleles on cognitive trajectory 
during the preclinical stage of disease are inconsistent. Two studies3, 11 found that those with 
higher education experienced on average a later change-point in their trajectory with 
subsequent faster decline. However, other studies have shown that education appears to 
influence the level of cognitive function but not the rate of decline.17, 18 Similarly, estimates 
of the effect of APOE genotype are inconsistent, with some studies indicating that subjects 
with ≥1 APOE ε4 alleles had a more rapid progression during the preclinical stage of 
AD.15, 19-21 Finally, sex is an important biological variable, yet its impact on cognitive 
trajectory has been considered in only a few studies.3, 22 The majority of longitudinal studies 
of cognitively normal adults either did not consider sex9 or adjusted for it as a 
covariate,4-7, 23 without considering further its impact on cognitive trajectory.
In this study, we used longitudinal data from a cohort of initially non-demented participants 
in the Adult Changes in Thought (ACT) study with up to 20 years of follow-up. Cognitive 
function was assessed using the CASI,24 a global cognitive test that has been used in large 
epidemiological cohort studies for detecting dementia.25-27 We aimed to estimate whether, 
relative to “normal” aging, there were changes in the CASI trajectory prior to dementia 
diagnosis and, if so, when these changes occurred. We defined “normal” aging to be the 
cognitive trajectory of individuals not diagnosed with dementia during follow-up. Our 
approach allowed us to assess, in subjects who would later be diagnosed with dementia, not 
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only early changes in cognitive trajectory relative to normal aging, but also the presence and 
timing of a change-point at which accelerated cognitive decline commenced and the 
magnitude of the changes in cognitive score before and after the change-point. We further 
assessed how the cognitive trajectory varied by sex, education and presence of ≥1 APOE ε4 
allele.
Methods
Participants
The ACT study design has been described elsewhere.27 Briefly, the initial cohort of 2,581 
community-based participants was randomly selected in 1994-1996 from Seattle area 
members of Group Health Cooperative (Kaiser Permanente Washington as of 2017). The 
base population was over 20,000 enrollees aged ≥ 65 years without dementia whose 
demographics were representative of surrounding counties. In 2000-2002, an expansion 
cohort (n=811) was added using the same sampling methods except oversampling clinics 
with higher proportions of minorities. Since 2005, a continuous enrollment strategy has been 
used to maintain a cohort of over 2,000 participants. The criteria for enrollment were a CASI 
score of ≥ 86 or absence of evidence of dementia after additional examination. Demographic 
characteristics, medical history, and suspected AD risk factors were obtained at the time of 
entry to the study and updated at every study visit. Of the 5,081 ACT participants as of May 
2015, 4,315 had at least one follow-up with a valid CASI score. For participants with 
incident dementia identified by the ACT study, we included data from all visits prior to 
diagnosis. For those subjects who were not diagnosed with dementia during follow-up, their 
records were censored in the analyses at their next to last visit to reduce misclassification of 
those who might subsequently have a diagnosis of dementia.
The study followed appropriate informed consent and had local IRB approval.
Cognitive assessment with the CASI
The CASI is a 40-item global cognitive test that assesses a broad range of cognitive 
domains, with total score of 0 - 100.24 CASI was administered at baseline and at each 
biennial follow-up visit and served as the screening tool for detecting dementia.
We used Item Response Theory (IRT) scores to address limited sensitivity at higher levels of 
cognitive functioning and nonlinear measurement properties of the CASI. In IRT, the 
construct of interest is regarded as a latent trait and each individual's responses to the 
individual items of the test are regarded as manifestations of this trait, which can be thought 
of as the “ability” of that individual at the time of testing. Two individuals with the same 
total (standard) CASI test score may have different IRT scores depending on the specific 
items they answered correctly. Unlike standard total test scores, IRT scores have linear 
scaling properties, i.e., a unit change in IRT corresponds to the same change in the 
underlying trait, regardless of the level of the trait.25, 28-30 Scores were scaled to have 
approximately mean 0 and standard deviation (SD) 1 at the 5th biennial visit, so CASI IRT 
can be thought of as being measured in approximately SD units.31 Figure S1 in 
Supplementary Material shows CASI IRT versus standard CASI scores for all individuals at 
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baseline and at their last visit, by dementia status at the time of censoring. In this study, we 
focus our primary analysis on estimating the average longitudinal trajectory of the CASI IRT 
score because of its better psychometric and statistical properties.25, 32
Diagnosis of dementia
In the ACT study, a CASI score of less than 86 was considered a screen positive for possible 
dementia. Those who screened positive underwent a standardized dementia diagnostic 
evaluation, including physical and neurological examination by a study physician and a 
battery of neuropsychological tests. Relevant laboratory tests and neuroimaging studies were 
performed or results were obtained from GHC records. Dementia diagnoses were assigned at 
consensus diagnostic conferences. All-cause dementia and its subtypes were determined 
based on the Diagnostic and Statistical Manual, 4th edition.33 Apolipoprotein E 
(APOE;GenBank, M12529) genotype was determined by a restriction digest method.34
Statistical analysis
Quantitative (/categorical) characteristics of study participants by dementia status were 
summarized by means, standard deviations and ranges (/frequencies). We used mixed effects 
linear regression to estimate mean longitudinal CASI IRT trajectories, using the records of 
all 4,315 subjects who had at least one follow-up with a valid CASI score. In individuals 
without diagnosis of dementia during follow-up, the mean CASI IRT score was assumed to 
change at a constant rate over time (age), where this trajectory represents “normal” aging. 
Linear cognitive trajectories have been demonstrated in a variety of settings.8, 9, 35 For those 
who were diagnosed with dementia during follow-up, the model for mean CASI IRT 
additionally included a piece-wise linear trajectory consisting of linear change with time to 
diagnosis until a change-point (at a time prior to diagnosis), after which there was possibly a 
different rate of linear change. Hence, the longitudinal trajectory model for those not 
diagnosed with dementia has a single slope parameter, corresponding to normal aging. For 
those who were diagnosed with dementia, their trajectories have two additional slope 
parameters, before and after an estimated change-point, representing the change in 
trajectory, relative to normal aging, as these individuals advance towards dementia diagnosis.
The model included intercept-level adjustment for the following covariates: dementia status, 
sex, education (college degree vs. no college degree) and baseline age cohort (>75 years vs. 
≤ 75 years at baseline) and random effects for study participant and the individual level 
trajectory slopes corresponding to normal aging. The primary analysis considered a common 
trajectory change-point for all individuals who were subsequently diagnosed with dementia. 
Sex, college education and baseline age cohort were assumed to affect the overall level of 
mean CASI IRT, but not the slopes and change-point of the longitudinal trajectory. 
Secondary analyses included interactions of the change-point and associated slope 
coefficients with (separately) college education, sex and presence of ≥1 APOE ε4 allele.
Model parameters were estimated by maximizing the likelihood using non-linear 
optimization. We tested specific hypotheses using likelihood ratio tests with 5% level of 
significance.
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We performed several sensitivity analyses. We repeated the primary trajectory analyses 
using standard CASI and the transformation ln (101-CASI), which has been used previously 
to address the skewness of the distribution of standard CASI scores.11 We also repeated the 
analysis including the last visit for subjects not diagnosed with dementia during follow-up. 
To assess the assumption of a (piece-wise) linear trajectory, we also estimated the time-to-
dementia and normal aging trajectories with fractional polynomials (FPs).36 In our study 
population, APOE genotype data were not available for 599 participants (14%). In further 
sensitivity analyses, all individuals with missing APOE ε4 status were assumed to be either 
ε4 negative or ε4 positive.
Analyses were carried out using R 3.3.2.37
Results
Characteristics of participants with and without dementia diagnosis
Table 1 shows study characteristics by eventual dementia status. Of 1,040 subjects who were 
diagnosed with dementia during follow-up, 636 had AD, 109 had vascular dementia, 185 
had mixed dementia, and 110 had other types of dementia. Compared to those not diagnosed 
with dementia during follow-up, those who developed dementia were less likely to be 
college educated, more likely to have ≥1 APOE ε4 allele, were older at enrollment and at 
last follow-up visit, and had lower mean CASI scores at enrollment and follow-up (all p-
values < 0.01).
Estimated CASI IRT trajectories and change-points
Figure 1A, B presents observed longitudinal CASI IRT scores by dementia diagnosis in 
individual participants during the study period with non-parametric smoothed trajectories. 
The smoothed trajectory for normal aging (those without diagnosis of dementia) is 
approximately linear. On visual inspection, the smoothed CASI IRT trajectory in those who 
would be diagnosed with dementia is lower than the trajectory of normal aging throughout 
follow-up and exhibits an accelerated decline at about 3 years prior to diagnosis.
Coefficient estimates for the CASI IRT primary trajectory model are summarized in Table 2. 
The estimated trajectory change-point (95% confidence interval (CI)) was at 3.1 (3.0, 3.2) 
years prior to diagnosis. The pre-change-point CASI IRT slope in those who would be 
diagnosed with dementia was significantly greater than the slope for normal aging: prior to 
the change-point, the mean annual decline in CASI IRT was more than double (0.041) the 
estimated annual decline associated with normal aging (0.015). After the change-point, the 
estimated annual decline in subjects who would be diagnosed with dementia increased 
markedly. Figure 1C, D shows CASI IRT spaghetti plots for individual subjects, and the 
estimated mean trajectories corresponding to normal aging and for those diagnosed with 
dementia at age 85, using the (piece-wise) linear trajectory models and FPs. The FP curves 
correspond closely to the estimated trajectories from the linear change-point models and also 
suggest a change-point at about 3 years prior to diagnosis.
Results of other sensitivity analyses were substantively in agreement with those of the 
primary analysis and are provided in Supplementary Tables S1 and S3.
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Differences in CASI IRT, relative to normal aging, in subjects with dementia diagnosis
We compared estimated mean CASI IRT scores from the primary model at 2, 5, 10, and 15 
years prior to dementia diagnosis to mean scores for individuals of the same age, age cohort, 
sex and education without dementia diagnosis (normal aging) (Table 3). The mean CASI 
IRT scores in those with subsequent dementia diagnosis were significantly lower (p < 0.01) 
than mean scores for those without diagnosis over the 15 years prior to diagnosis. 
Participants who would be diagnosed with dementia 10 years later are estimated to have 
mean CASI IRT 0.21 units lower than participants of the same age, age cohort, sex and 
education who were not diagnosed with dementia during follow-up.
Effect of sex, education and APOE genotype on CASI IRT trajectory
The average IRT and standard CASI scores differed significantly by sex, education and 
presence of ≥1 APOE ε4 alleles. Based on the primary trajectory model, males had mean 
CASI IRT scores 0.16 (95% CI 0.13, 0.19) units lower than females (adjusting for age, age 
cohort and education). Those without a college education had adjusted mean CASI IRT 
scores 0.29 (95% CI 0.26, 0.33) units lower than those with a college education. Including 
≥1 APOE ε4 alleles as an intercept adjustment in the primary model, those with ≥1 APOE 
ε4 alleles had adjusted mean CASI IRT 0.05 (95% CI 0.01, 0.08) lower than those with no 
APOE ε4 alleles.
There were no other major differences in estimated trajectories by sex, education and APOE 
ε4 genotype. (Supplementary Table S2 and Figure S2). When trajectory models were fitted 
including interactions, the location of the change-point did not differ by (separately) sex, 
education or having ≥1 APOE ε4 alleles (p > 0.13). There were statistically significant, but 
small, differences in post-change-point slope by sex and in pre-change-point slope by 
presence of APOE ε4 allele.
Discussion
In this community-based study, we found that, on average, compared to normal aging, 
increased cognitive decline measured by CASI IRT was present at least 10 years prior to 
clinical diagnosis of dementia, followed by an accelerated decline at about 3 years prior to 
the diagnosis. Male sex, lower education and presence of ≥1 APOE ε4 alleles were 
associated, on average, with lower cognitive performance, but these factors had less impact 
on the shape of cognitive trajectory in those who developed dementia.
In persons not diagnosed with dementia, average CASI IRT declined slowly with aging. In 
contrast, the average early rate of decline in those who were later diagnosed with dementia 
was more than double that of normal aging, such that differences in average scores were 
statistically evident up to 15 years prior to clinical diagnosis of dementia. This early decline 
in cognition measured with a brief cognitive test is largely consistent with recent 
observations of cognitive changes from other large community-based studies.5-7
Our study suggests that acceleration of global cognitive decline assessed by a brief cognitive 
measure occurred on average about 3 years prior to dementia diagnosis. This is consistent 
with the finding in another community-based study of accelerated decline 3 years prior to 
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dementia diagnosis in standard scores from the Mini-Mental State Examination (MMSE).4 
A study using data from a research clinic setting showed a slight earlier change-point in the 
MMSE, 5 years prior to AD diagnosis.8 However, the risk profile of these subjects may be 
different from that in a community-based study such as ours.38 The timing of the 
acceleration of cognitive decline prior to dementia diagnosis may also vary with type of 
cognitive measure.4, 9, 12, 16
Previous studies have generally shown no difference in rate of cognitive decline between 
men and women.3, 22 Our finding of a lower average cognitive performance in men than in 
women is consistent with our earlier findings of poorer executive function39 in men than in 
women in a different cohort; and consistent with the observation that men had poorer 
memory and smaller hippocampal volume and that memory and hippocampal volume 
decline began at earlier ages than brain Aβ deposition.40 We speculate that this greater 
cognitive decline in men may be due to increased cerebrovascular disease in men.41, 42
Education is an important factor in assessment of cognitive function and potentially affects 
cognitive trajectory changes, although it has been suggested that the impact is stronger in 
younger adults.5, 6, 15, 23, 43-46 Higher education is consistently associated with better 
cognitive performance 5, 6, 15, 23, 44, 46, 47 but estimates of the effect of education on 
cognitive trajectory changes are less consistent and may vary by domain.5, 6, 15, 35, 44, 46, 47 
Some studies3, 15, 44 showed that persons with higher education level have a change-point 
closer to diagnosis and a more rapid decline of cognitive function after the change-point. 
However, as in other studies,23, 46 while we found that the mean CASI score was 
significantly higher in those with higher education, we did not find a significant effect of 
college vs no college on the trajectory. The discrepancy with previous findings could be due 
to the relatively low sensitivity of the CASI, compared to specific measurement of memory 
or more extensive neuropsychological test batteries used in other studies.15, 44 Also, the 
education effect on CASI score might be at a lower threshold,48 which could not be 
adequately assessed in our cohort with high average education levels.
Cognitive trajectory change prior to clinical diagnosis of dementia is also determined by the 
underlying disease process which could vary by APOE genotype.15, 20 Yu et al. reported that 
the presence of APOE ε4 alleles was associated with more rapid cognitive decline measured 
by the MMSE both before and after the change-point.15 We observed a slightly faster 
decline in those with ≥1 APOE ε4 alleles prior to, but not after, the change-point. Other 
longitudinal studies3, 6, 21 did not identify changes during the pre-dementia stage in the 
MMSE trajectory by presence of APOE ε4. Again, a potential explanation is the low 
sensitivity of brief cognitive tests in measuring subtle cognitive impairments prior to 
dementia diagnosis.
Relative to other studies of cognitive decline, a major strength of this study is that our 
findings are based on a large community-based cohort with long follow-up up to 20 years. 
Nevertheless, a potential limitation is that in ACT, the CASI was measured every two years 
rather than yearly, which may delay diagnosis of dementia. Another limitation is that our 
piece-wise linear trajectory model was not designed to estimate at what point prior to 
diagnosis those who develop dementia deviate from normal aging.
Li et al. Page 7
J Am Geriatr Soc. Author manuscript; available in PMC 2018 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
In conclusion, our findings suggest that commonly used brief cognitive measures, such as 
the CASI, could exhibit differences in cognitive functioning at least 10 years prior to clinical 
diagnosis, with decline accelerating about 3 years prior to clinical diagnosis. Sex, education 
and APOE genotype affect average level of cognitive performance but had little impact on 
the shape of the cognitive trajectory prior to diagnosis of dementia.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. CASI IRT trajectories by dementia status
Upper panels (A, B): CASI IRT scores by time to diagnosis for those diagnosed with 
dementia (A) or time to censoring† for normal aging (B) for the entire study sample.
Solid lines correspond to non-parametric loess smoothed trajectories
†Records for those not diagnosed with dementia were censored at the next to last visit.
Lower panels (C,D): Individual observed and estimated mean age trajectories for those 
diagnosed with dementia at age 85 (C) or normal aging censored at age 85 (D). For college 
educated females in the 75 and under baseline age cohort.
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Solid black line: fitted (piece-wise) linear primary models
Dashed black line: fitted fractional polynomial (FP) models
The components of the fitted FP model for normal aging are of the form ((age + 10.1)/10)2 
and ((age + 10.1)/10)3, where age was centered at 75 years, and for time to dementia 
diagnosis (t) are of the form: ((t + 0.1)/10)-0.5 and ((t + 0.1)/10)-0.5 * log(((t + 0.1)/10)).
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Table 1
Characteristics of ACT study participants in the analysis
Normal aging (n=3275) Diagnosed with dementia (n=1040)
Mean, SD (range)
Age at enrollment (years) 73.5, 6.1 (65-101) 76.7, 6.3 (65-96)
Age at diagnosis of dementia/last visit (years) 81.6, 7.3 (67-107) 85.3, 6.0 (68-103)
Follow-up time to last visit (years) 8.0, 5.3 (1-20) 8.6, 4.7 (1-20)
Baseline standard CASI score 94.3, 4.2 (65-100) 91.5, 5.4 (62-100)
Standard CASI score at time of dementia diagnosis/censoring*† 93.9, 4.5 (59-100) 77.8, 9.9 (14-99)
Baseline CASI IRT score 0.42, 0.67 (-2.12, 1.75) -0.02, 0.73 (-1.98, 1.75)
CASI IRT score at time of dementia diagnosis/censoring*‡ 0.35, 0.68 (-2.86, 1.75) -1.32, 0.63 (-3.97, 1.46)
Frequency (%)
Female 1891 (58) 645 (62)
With college degree 2388 (73) 610 (59)
≥1 APOE ε4 allele†† 669 (24) 306 (34)
CASI: Cognitive Abilities Screening Instrument (score 0-100); IRT: Item Response Theory. CASI IRT score were scaled to have approximately 
mean 0 and standard deviation 1 at the 5th biennial visit.
*Censored at next to last visit.
†163 participants who were diagnosed with dementia did not have valid CASI scores at diagnosis and 20 subjects who were not diagnosed with 
dementia were missing CASI scores at last visit;
‡166 participants who were diagnosed with dementia did not have valid CASI IRT scores at diagnosis and 31 subjects who were not diagnosed 
with dementia were missing CASI IRT scores at last visit;
††Not available for 466 participants with no dementia and 138 participants who were diagnosed with dementia.
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Table 3
Estimated mean differences† (95% CI) in CASI IRT comparing normal aging to those 
diagnosed with dementia, at selected years from diagnosis
Years from diagnosis Mean difference (95% CI)*
15 years 0.08 (0.02, 0.13)
10 years 0.21 (0.17, 0.25)
5 years 0.34 (0.30, 0.38)
2 years 0.85 (0.81, 0.89)
CASI IRT score: Cognitive Abilities Screening Instrument Item Response Theory score were scaled to have approximately mean 0 and standard 
deviation 1 at the 5th biennial visit; CI: confidence interval.
†
For subjects of the same sex, age, age cohort and education level;
*
Estimated from the primary trajectory model.
J Am Geriatr Soc. Author manuscript; available in PMC 2018 December 01.
